FFP and cryo both come from donated plasma, but they answer different problems. FFP replaces all the clotting proteins at once, while cryo delivers a concentrated dose of mainly one, fibrinogen. The choice usually comes down to whether the bleeding person is short of everything or short of fibrinogen in particular. They are partners more than rivals, and in severe bleeding many people receive both. The more concentrated product isn’t automatically the life-saver, though: in trauma, giving cryo earlier or more often has not been shown to save lives, so when it is given matters as much as which one.
What Is Actually in FFP and Cryo
Plasma is the straw-coloured liquid part of blood. Clotting factors are proteins in it that work in a chain to build a clot. FFP, short for fresh frozen plasma, holds all of these clotting proteins, including fragile ones such as factors V and VIII.1Australian Red Cross Lifeblood. Fresh frozen plasma It also carries the body’s natural anti-clotting proteins, plus albumin and antibodies.2Medicina Intensiva (English Edition). Clinical efficacy of fresh frozen plasma compared with coagulation factor concentrates for treating coagulopathy in patients with massive bleeding One FFP bag holds about 245 mL of fluid.3PubMed. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma Exact amounts vary from donor to donor and with how the plasma was prepared.4Medicina Intensiva (English Edition). Clinical efficacy of fresh frozen plasma compared with coagulation factor concentrates for treating coagulopathy in patients with massive bleeding
Cryoprecipitate, or cryo, is made by slowly thawing frozen plasma and collecting the protein-rich sludge that stays solid.5International Journal of Clinical Transfusion Medicine. Cryoprecipitate transfusion: current perspectives So each cryo bag holds only about 21 mL of fluid.6PubMed. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma It is rich in fibrinogen, the protein that forms the mesh of a clot, plus factor VIII, von Willebrand factor and factor XIII.7International Journal of Clinical Transfusion Medicine. Cryoprecipitate transfusion: current perspectives
Many people assume cryo has more fibrinogen per bag. It doesn’t. One FFP bag actually contains more total fibrinogen, about 725 mg versus 183 mg in a cryo bag.8PubMed. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma Cryo has more per millilitre. To raise fibrinogen with FFP alone, you would need many bags and a lot of fluid, and that trade-off between dose and fluid volume drives most choices between the two.
That is also why cryo is pooled. Because each bag is so small, an adult dose is usually several bags together, so one order can involve units made from several different donors.
When FFP Is the Right Choice
Doctors use FFP when a broad range of clotting proteins is needed.9Western Cape Blood Service. Cryo or FFP? – Western Cape Blood Service Massive bleeding is the classic case, because it uses up everything. Clotting proteins are consumed as the body tries to plug many wounds at once. Replacing lost blood with red cells and salt water alone dilutes whatever proteins remain.
So in massive bleeding, hospitals run a protocol that gives red cells, platelets and FFP together, usually in roughly equal 1:1:1 amounts.10EMCrit Project. Massive Transfusion/Hemorrhage Protocol In injured people needing big transfusions, giving more plasma alongside red cells has been linked to better survival.11PubMed. Fresh frozen plasma (FFP) use during massive blood transfusion in trauma resuscitation The benefit seems to level off at high plasma ratios, which suggests there is a best balance rather than “more is better.”12JAMA Surgery. High Fresh Frozen Plasma to Red Blood Cell Ratio and Survival Outcomes in Blunt Trauma The ratio is a starting point for the first hours, and teams adjust it once lab results and the patient’s response are known.
FFP is also used to reverse warfarin, which lowers several clotting proteins at once. FFP replaces all of them.13PubMed Central. Application of fresh frozen plasma transfusion in the management of excessive warfarin-associated anticoagulation At one large US hospital, 60% of FFP units used in a month went to reversing warfarin.14PubMed. Warfarin reversal emerging as the major indication for fresh frozen plasma use at a tertiary care hospital Many hospitals now prefer a concentrated factor product for urgent warfarin reversal, with FFP as a backup.
Speed of supply is a practical limit. FFP is stored frozen, so the wait for thawing slows its arrival in an emergency.15Australian and New Zealand Society of Blood Transfusion Ltd. Extended Life Plasma: A Framework for Preparation, Storage and Use To get around this, some hospitals keep already-thawed plasma in the fridge for up to 5 days so it can go out right away.16Australian and New Zealand Society of Blood Transfusion Ltd. Extended Life Plasma: A Framework for Preparation, Storage and Use
When Cryo Is the Better Fit
Cryo is chosen when the specific need is fibrinogen.17Western Cape Blood Service. Cryo or FFP? – Western Cape Blood Service Fibrinogen often falls first and fastest in heavy bleeding. Its normal level is higher than that of most other clotting proteins, yet in some bleeds it can still drop below the level needed before the others do. A measured low fibrinogen is therefore a more specific signal for cryo than the general sense that someone is bleeding a lot.
Volume is the other reason. People with cirrhosis or weak hearts can’t easily handle extra litres of fluid, which can back up into the lungs. In people with cirrhosis, cryo is preferred over FFP for low fibrinogen during blood loss because FFP’s volume is so large.18aasld.org. Peri-Procedural Management of Bleeding Risk in Cirrhosis
Childbirth bleeding is a good example. The placenta site bleeds heavily and burns through fibrinogen quickly, and a low fibrinogen early in the bleed signals it may become severe. That is why some maternity units check fibrinogen fast and keep cryo nearby. In an early trial, giving cryo early in severe postpartum bleeding was linked to fewer red cell transfusions and fewer intensive care admissions, with no rise in clots or serious side effects.19PubMed Central. Early cryoprecipitate transfusion versus standard care in severe postpartum haemorrhase: a pilot cluster-randomised trial It was a small pilot, so the result is encouraging rather than settled.20PubMed Central. Early cryoprecipitate transfusion versus standard care in severe postpartum haemorrhase: a pilot cluster-randomised trial In women with preeclampsia and severe postpartum bleeding, prompt cryo may reduce further bleeding.21PubMed. Efficacy of prompt administration of cryoprecipitate in severe postpartum hemorrhage of preeclampsia patients
Cryo can also treat von Willebrand disease, hemophilia A or factor XIII deficiency, but only when the proper purified factor products are unavailable or other drugs won’t work.22Lablogatory. Cryoprecipitate 101 That was not always so. Cryo was first introduced in 1965 for hemophilia A, before purified factors existed.23Pathology. Cryoprecipitate – a quarter of a century on
How Doctors Decide in the Moment
A normal fibrinogen level is roughly 2 to 4 g/L, which some reports list as 200 to 400 mg/dL. Many guidelines aim to keep fibrinogen above about 100 to 120 mg/dL during acute blood loss.24aasld.org. Peri-Procedural Management of Bleeding Risk in Cirrhosis Many trauma and obstetric protocols use a higher trigger of 1.5 to 2 g/L. The reason for acting on the low end is that in critically bleeding patients, death risk climbs steeply once fibrinogen falls below about 1.3 g/L.25PubMed Central. Association between fibrinogen levels and prognosis in critically bleeding patients: exploration of the optimal therapeutic threshold Raising it past about 2.0 to 2.5 g/L shows no extra survival benefit.26PubMed Central. Association between fibrinogen levels and prognosis in critically bleeding patients: exploration of the optimal therapeutic threshold
Labs report fibrinogen either in g/L or in mg/dL, and 1 g/L equals 100 mg/dL. Check the unit first, since “1.5” and “150” can be the same level.
TEG and ROTEM are bedside tests that watch a blood sample form a clot and measure how fast and how firm it is. A clot that starts on time but is weak points to low fibrinogen or platelets, treated with cryo and platelets.27WakeMed. TEG Therapy Algorithm for Clotting Dysfunction for Trauma A clot that starts late but ends up strong points to missing clotting proteins, treated with 1 to 2 units of FFP.28WakeMed. TEG Therapy Algorithm for Clotting Dysfunction for Trauma When both start time and strength are off, FFP, platelets and cryo may all be given.29WakeMed. TEG Therapy Algorithm for Clotting Dysfunction for Trauma
Lab fibrinogen results can take longer than the bedside clot tests, so teams often act on the bedside reading first. Fibrinogen products work best given early and guided by these clot-strength readings.30PubMed. Current perspective on fibrinogen concentrate in critical bleeding
The machine a hospital owns can shape the choice. ROTEM-based plans tend to recommend cryo more often, while TEG-based plans lean toward FFP.31Deranged Physiology. Viscoelastic tests of clotting function Each hospital follows its own algorithm, so two hospitals may treat a similar patient differently without either being wrong.
Does the Choice Change Survival
In trauma, earlier cryo did not save lives. Standard care has often given cryo only after several units of blood and the first plasma.32PubMed Central. Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs In a large trial in injured patients, a high early dose of cryo was given in about an hour instead of two.33JAMA. Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury Deaths at 28 days were almost the same, 25.3% with early cryo and 26.1% with usual care.34JAMA. Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury
That trial tested a set early dose given to nearly everyone, not cryo for patients with a measured low fibrinogen. So its result does not say cryo is useless, only that routine early use did not help. Targeted use in patients with a proven shortage remains a separate and reasonable question.
Heart surgery tells a different story. Among patients already getting platelets for bleeding, those given extra FFP instead of cryo were about 1.5 times as likely to die after surgery.35PubMed. Adjunctive Fresh Frozen Plasma Versus Adjunctive Cryoprecipitate in Cardiac Surgery Patients Receiving Platelets for Perioperative Bleeding They also had more kidney injury, more infections and longer intensive care stays.36PubMed. Adjunctive Fresh Frozen Plasma Versus Adjunctive Cryoprecipitate in Cardiac Surgery Patients Receiving Platelets for Perioperative Bleeding But this came from records, not a trial, so sicker patients may simply have received FFP.
In critically ill people with cirrhosis, treating very low fibrinogen with cryo did not reduce bleeding or deaths.37PubMed. Transfusion with Cryoprecipitate for Very Low Fibrinogen Levels Does Not Affect Bleeding or Survival in Critically Ill Cirrhosis Patients In that group, low fibrinogen mainly reflects how sick the liver is rather than causing the bleeding.38PubMed. Transfusion with Cryoprecipitate for Very Low Fibrinogen Levels Does Not Affect Bleeding or Survival in Critically Ill Cirrhosis Patients This is why doctors treat a low level alongside signs of active bleeding, not alone.
Risks of FFP and Cryo
TRALI, transfusion lung injury, is a rare but serious reaction causing sudden breathing trouble within 6 hours of a transfusion.39Professional Education. Transfusion-related acute lung injury (TRALI) Antibodies in donor plasma can set off the recipient’s white blood cells, making lung blood vessels leak.40Australian Red Cross Lifeblood. Transfusion-related acute lung injury (TRALI) So blood services avoid using plasma from donors likely to carry those antibodies, such as people who have been pregnant.41Australian Red Cross Lifeblood. Transfusion-related acute lung injury (TRALI) Services therefore often use plasma from male donors, or from women tested and found unlikely to carry the antibodies. That lowers the chance of a lung reaction but cannot remove it. Every plasma-containing product has been linked to it, including rare cases with cryo.42Professional Education. Transfusion-related acute lung injury (TRALI)
Standard plasma can still carry blood-borne viruses that routine HIV and hepatitis screening doesn’t catch.43PubMed. Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy Bacteria can survive the standard way cryo is made.44PubMed Central. Comparison of Bacterial Risk in Cryo AHF and Pathogen Reduced Cryoprecipitated Fibrinogen Complex A newer pathogen-reduced cryo product stayed sterile through its whole shelf life.45PubMed Central. Comparison of Bacterial Risk in Cryo AHF and Pathogen Reduced Cryoprecipitated Fibrinogen Complex Large FFP volumes can also overload the circulation, especially in people with heart or kidney problems.
After a plasma transfusion, new shortness of breath or a drop in oxygen during or within hours of the transfusion needs reporting. Fever, chills or a rash can signal a reaction. If any appear, staff stop the transfusion and check vital signs.
Fibrinogen Concentrate as an Alternative to Cryo
Fibrinogen concentrate is a purified, virus-treated powder mixed with water at the bedside. It can be given without thawing or blood-type matching, sits on a shelf, and can be prepared within minutes of the decision. It contains mainly fibrinogen and factor XIII, lacking the other proteins cryo carries.46PubMed Central. Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate
In a large heart surgery trial, patients given concentrate needed about the same blood transfusions as those given cryo, 16.3 versus 17.0 units in a day.47JAMA. Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial Pooled heart surgery studies show no difference in deaths, blood loss, clots or infections between the two.48PubMed Central. Treatment effects of fibrinogen concentrates vs. cryoprecipitate for correcting hypofibrinogenemia in cardiac surgery patients: a systematic review and meta-analysis In children bleeding after heart surgery, concentrate and cryo led to similar blood loss.49PubMed Central. Pediatric Fibrinogen PART II—Overview of Indications for Fibrinogen Use in Critically Ill Children In the large trial’s cost analysis, concentrate was cheaper, about CAD $2,280 versus $2,770 in blood product costs per patient over a week.502 Minute Medicine. Fibrinogen concentrate may be cost-effective for bleeding management in adult cardiac surgery patients The speed advantage is mainly practical, since the trials show similar blood use rather than a clear survival advantage.
Many hospitals still use cryo. Availability and approval of concentrate vary by country and hospital. Cryo also supplies factor VIII and von Willebrand factor, which concentrate lacks, and some blood banks already stock cryo, so switching takes planning.